BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17227295)

  • 1. Pharmacodynamics of T-cell function for monitoring immunosuppression.
    Barten MJ; Tarnok A; Garbade J; Bittner HB; Dhein S; Mohr FW; Gummert JF
    Cell Prolif; 2007 Feb; 40(1):50-63. PubMed ID: 17227295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
    Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
    Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients.
    Barten MJ; Rahmel A; Garbade J; Richter M; Bittner HB; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2005 Mar; 37(2):1360-1. PubMed ID: 15848720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
    Barten MJ; Dhein S; Chang H; Bittner HB; Tarnok A; Rahmel A; Mohr FW; Gummert JF
    J Immunol Methods; 2003 Dec; 283(1-2):99-114. PubMed ID: 14659903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
    Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
    Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications.
    Sindhi R; Allaert J; Gladding D; Haaland P; Koppelman B; Dunne J; Sehgal S
    J Immunol Methods; 2003 Jan; 272(1-2):257-72. PubMed ID: 12505729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response.
    Rigol M; Solanes N; Sionis A; Gálvez C; Martorell J; Rojo I; Brunet M; Ramírez J; Roqué M; Roig E; Pérez-Villa F; Barquín L; Pomar JL; Sanz G; Heras M
    J Heart Lung Transplant; 2008 Apr; 27(4):416-22. PubMed ID: 18374878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
    Berry V; Magill A; Yost M; Janosky J; Sindhi R
    Cytometry A; 2006 Feb; 69(2):95-103. PubMed ID: 16369935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.
    Rostaing L; Puyoo O; Tkaczuk J; Peres C; Rouzaud A; Cisterne JM; de Preval C; Ohayon E; Durand D; Abbal M
    Clin Transplant; 1999 Oct; 13(5):400-9. PubMed ID: 10515221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
    Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
    Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.
    Barten MJ; Shipkova M; Bartsch P; Dhein S; Streit F; Tarnok A; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
    Ther Drug Monit; 2005 Apr; 27(2):123-31. PubMed ID: 15795640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation.
    Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
    Transpl Infect Dis; 2014 Jun; 16(3):379-86. PubMed ID: 24666466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.
    Barten MJ; Gummert JF; van Gelder T; Shorthouse R; Morris RE
    J Immunol Methods; 2001 Jul; 253(1-2):95-112. PubMed ID: 11384672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression.
    Härtel C; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
    Clin Chem; 2002 Dec; 48(12):2225-31. PubMed ID: 12446480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel apoptosis assay to analyze immunosuppression.
    Boldt A; Barten MJ; Weiss C; Sagner A; Mohr FW; Gummert JF
    Cytometry A; 2006 Mar; 69(3):158-60. PubMed ID: 16479615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophyllin ligands show differential effects on alcohol self-administration in C57BL mice.
    Beresford T; Fay T; Serkova NJ; Wu PH
    J Pharmacol Exp Ther; 2012 Jun; 341(3):611-6. PubMed ID: 22375069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts.
    Jiang H; Yang X; Soriano RN; Fujimura T; Krishnan K; Kobayashi M
    Immunobiology; 2000 Sep; 202(3):280-92. PubMed ID: 11045663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
    Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.